Jung‐Yoon Choe

ORCID: 0000-0003-0957-0395
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Gout, Hyperuricemia, Uric Acid
  • Inflammasome and immune disorders
  • Spondyloarthritis Studies and Treatments
  • Lymphoma Diagnosis and Treatment
  • Biosimilars and Bioanalytical Methods
  • Systemic Sclerosis and Related Diseases
  • Osteoarthritis Treatment and Mechanisms
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chronic Lymphocytic Leukemia Research
  • Hepatitis C virus research
  • Cytokine Signaling Pathways and Interactions
  • Healthcare and Venom Research
  • Monoclonal and Polyclonal Antibodies Research
  • Ocular Diseases and Behçet’s Syndrome
  • Inflammatory mediators and NSAID effects
  • Salivary Gland Disorders and Functions
  • Bone and Joint Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Immune Cell Function and Interaction
  • Pharmaceutical studies and practices
  • Psoriasis: Treatment and Pathogenesis
  • Atherosclerosis and Cardiovascular Diseases

Catholic University of Daegu
2016-2025

Daegu Catholic University Medical Center
2015-2023

Center for Rheumatology
2020-2022

Weatherford College
2021

Chonnam National University Hospital
2017

Alba Graduate Business School, The American College of Greece
2014

St. Paul's Hospital
2013

Institute of Biomedical Science
2007

University of California, San Diego
2003

Roy Fleischmann Eduardo Mysler Stephen Hall Alan Kivitz Robert J. Moots and 95 more Zhen Luo Ryan DeMasi Koshika Soma Richard Zhang Liza Takiya Svitlana Tatulych Christopher F. Mojcik Sriram Krishnaswami Sujatha Menon Josef S Smolen Luthando Adams Mahmood M. T. M. Ally Maria C du Plooy Ingrid Louw Savithree Nayiager Christoffel B Nel Debra Nel Helmuth Reuter Ahmed S Soloman Catherine Elizabeth Spargo Stephen Hall Maureen Rischmueller S Sharma Robert Will Peter Youssef Caroline Arroyo Rosario P Baes Roger B Dulos Llewellyn T. Hao A Lanzon Juan Javier Lichauco Jill H Mangubat Edgar Ramiterre Bernadette Heizel M. Reyes Perry Pua Tan Jung‐Yoon Choe Young Mo Kang Seong‐Ryul Kwon Sang‐Heon Lee Shin‐Seok Lee Dae‐Hyun Yoo Hsiao-Yi Lin Shue‐Fen Luo Shih-Tzu Tsai Wen‐Chan Tsai Jui-Cheng Tseng James Cheng‐Chung Wei Paijit Asavatanabodee Kanokrat Nantiruj Surasak Nilganuwong Parichat Uea‐Areewongsa Ljubinka Bozic Majstorovic Suada Mulic Bacic Anastas Batalov Gabriela Georgieva-Slavcheva Mariyana Mihailova Nikolay G Nikolov Dimitar P Penev Yuliy A Spasov Krasimira Stanimirova Stoyan Todorov Antoaneta A. Toncheva Nadezhda Yordanova Zdenka Mosterova Libor Novosád Leona Procházková Helena Stehlikova Zuzana Stejfova Natalia Kiseleva Lea Pank Triin Savi Balbir-Gurman Alexandra Howard Amital Dror Mevorach Itzhak Rosner Anna Mihailova Evija Stumbra-Stumberga Vida Basijokiene Virginija Lietuvininkiene Dalia Unikienė Jan Brzezicki Anna Dudek Maria B Glowacka-Kulesz Barbara Grabowicz-Wasko Sabina Hajduk-Kubacka Joanna Hilt Paweł Hrycaj Sławomir Jeka Renata Kolasa Marek Krogulec Hanna Mastalerz Anna Olak-Popko E Owczarek Zofia Ruzga Alina Walczak

10.1016/s0140-6736(17)31618-5 article EN The Lancet 2017-06-16
Brad H. Rovin Neil Solomons William F. Pendergraft Mary Anne Dooley James A. Tumlin and 95 more Juanita Romero‐Díaz Lidia V. Lysenko Sandra Navarra Robert B. Huizinga Ihar Adzerikho Е. И. Михайлова N. P. Mitkovskaya Sergey Pimanov Nikolay Soroka Boris Bogov Boriana Deliyska Valentin Ikonomov Eduard Tilkiyan Ruth Almeida José Fernando Jiménez Díaz Faud Teran Irma Tchokhonelidze N I Tsiskarishvili Maynor Herrera Mendez Nilmo Noel Chavez Perez Arturo Reyes Loaeza Sergio Ramon Gutierrez Urena Juanita Romero Diaz Rodolfo Araiza Casillas Magdalena Madero Rovalo Stanisław Niemczyk Antoni Sokalski Andrzej Wiȩcek Marian Klinger О. В. Бугрова Татьяна Михайловна Черных Т. R. Kameneva Lidia V. Lysenko Т. А. Раскина O. V. Reshetko Н. Н. Везикова Tatiana Kropotina Adelya Maksudova Vyacheslav Marasaev Vladimir Dobronravov И. Г. Гордеев A. Essaian А. В. Фролов Rosa Jelačić Dragan Jovanović Branka Mitić Gordana Peruničić Peković M Radović Goran Radunović Patrícia Carreira Federico Dı́az-González Xavier Fulladosa Eduardo Úcar Shamila De Silva Chula Herath Anura Hewageegana Abdul Nazar Abdul Wazil І. Dudar Olga Godlevska Svitlana Korneyeva ViktoriIa Vasylets N. Sydor М. Kolesnyk Samir V. Parikh Nancy J. Olsen Ellen M. Ginzler James A. Tumlin Amit Saxena Ramesh Saxena Richard A. Lafayette William F. Pendergraft Amber S. Podoll Annie Arrey‐Mensah M Bubb Jennifer M. Grossman Alejandro I. Oporta Alireza Nami Md Mujibur Rahman Syed Atiqul Haq Tak Mao Chan Mok Mo Yin Temy Harold Michael P. Gomez James Bermas Bernadette Heizel M. Reyes Llewellyn T. Hao Linda Charmaine Roberto Eric Amante Sandra Navarra A Lanzon Jung‐Yoon Choe Tae Young Kang Yon Su Kim Seung‐Geun Lee Ji Soo Lee

10.1016/j.kint.2018.08.025 article EN publisher-specific-oa Kidney International 2018-11-09

Objective To investigate baseline and change of pulmonary damage biomarkers (serum Krebs von den Lungen 6 [KL-6], human surfactant protein D [hSP-D], matrix metalloproteinase 7 [MMP-7]) with rheumatoid arthritis–associated interstitial lung disease (RA-ILD) progression. Methods In the Korean Rheumatoid Arthritis Interstitial Lung Disease (KORAIL) cohort, a prospective we enrolled patients RA ILD confirmed by chest computed tomography imaging followed annually. progression was defined as...

10.3899/jrheum.2024-0713 article EN The Journal of Rheumatology 2025-01-15

Inflammatory arthritis is associated with the release of a network key cytokines. In T cell receptor transgenic K/BxN mice interleukin (IL)-1 plays role in joint swelling and destruction, as suggested by ability anti–IL-1receptor (IL-1R) antibody treatment to delay onset slow progression this disease. This mechanism dependent on signaling pathway intermediary myeloid differentiation factor 88 (MyD88), such that neither IL-1R nor MyD88-deficient developed visually detectable synovitis after...

10.1084/jem.20021850 article EN The Journal of Experimental Medicine 2003-02-10

<h3>Objectives</h3> To compare the efficacy, safety, immunogenicity and pharmacokinetics (PK) of SB2 to infliximab reference product (INF) in patients with moderate severe rheumatoid arthritis (RA) despite methotrexate therapy. <h3>Methods</h3> This is a phase III, randomised, double-blind, multinational, multicentre parallel group study. Patients RA therapy were randomised 1:1 ratio receive either or INF 3 mg/kg. The primary end point was American College Rheumatology 20% (ACR20) response...

10.1136/annrheumdis-2015-207764 article EN cc-by-nc Annals of the Rheumatic Diseases 2015-12-01

Efficacy, safety and immunogenicity results from the phase III study of SB2, a biosimilar reference infliximab (INF), were previously reported through 54 weeks. This transition period compared in patients with rheumatoid arthritis (RA) who switched INF to SB2 those maintained treatment or SB2.Patients moderate severe RA despite methotrexate randomised (1:1) receive at weeks 0, 2 6 every 8 thereafter until week 46. At 54, receiving rerandomised switch (INF/SB2 (n=94)) continue on (INF/INF...

10.1136/annrheumdis-2017-211741 article EN cc-by-nc Annals of the Rheumatic Diseases 2017-10-17

<h3>Objective</h3> A highly polygenic aetiology and high degree of allele-sharing between ancestries have been well elucidated in genetic studies rheumatoid arthritis. Recently, the high-density genotyping array Immunochip for immune disease loci identified 14 new arthritis risk among individuals European ancestry. Here, we aimed to identify using Korean-specific data. <h3>Methods</h3> We analysed Korean case–control samples genome-wide association (GWAS) search alleles with...

10.1136/annrheumdis-2013-204749 article EN Annals of the Rheumatic Diseases 2014-02-14

Abstract Background The impact of sarcopenia on clinical outcomes coronavirus disease 2019 (COVID-19) is not clearly determined yet. We aimed to investigate the association between baseline and in patients with COVID-19. Methods All hospitalized adult COVID-19 who had chest computed tomography (CT) scans at a Korean university hospital from February 2020 May were included. main outcome was time admission discharge. Death considered as competing risk for Baseline skeletal muscle...

10.1093/gerona/glab085 article EN other-oa The Journals of Gerontology Series A 2021-03-29

To explore the course of lung function and RA disease activity predictive factors for deteriorating in patients with RA-interstitial (ILD).The Korean Rheumatoid Arthritis-Interstitial Lung Disease cohort is a multicentre, prospective observational cohort. Patients RA-ILD were enrolled followed up annually 3 years ILD status assessment. Group-based modelling was used to cluster similar predicted percentage forced vital capacity (FVC%) patterns into trajectories.This study included 140 who...

10.1093/rheumatology/kead027 article EN cc-by-nc Lara D. Veeken 2023-01-25

Objective To investigate the risk of cardiovascular disease (CVD) associated with increasing dose a non-steroidal anti-inflammatory drug (NSAID) in patients ankylosing spondylitis (AS). Methods Using Korean National Health Insurance database, newly diagnosed AS without prior CVD between 2010 and 2018 were included this nationwide cohort study. The primary outcome was CVD, composite ischaemic heart disease, stroke or congestive failure. Exposure to NSAIDs evaluated using time-varying...

10.1136/ard-2023-225406 article EN Annals of the Rheumatic Diseases 2024-04-09

It has been suggested that hyperuricemia and possibly gout are associated with the metabolic syndrome, but there have no direct studies. This study was undertaken to obtain prevalence of syndrome in patients compare it those from general population a 4-institutional case-historical control composed 168 gout. We assessed according ATP III criteria compared historical controls. To elucidate factors were multivariate analysis done. The age-adjusted 43.6%, which significantly higher than Korean...

10.3346/jkms.2005.20.6.1029 article EN Journal of Korean Medical Science 2005-01-01

Recent reports have associated NCF2, encoding a core component of the multi-protein NADPH oxidase (NADPHO), with systemic lupus erythematosus (SLE) susceptibility in individuals European ancestry. To identify ethnicity-specific and -robust variants within we assessed 145 SNPs around NCF2 gene 5325 cases 21 866 controls European-American (EA), African-American (AA), Hispanic (HS) Korean (KR) Subsequent imputation, conditional, haplotype bioinformatic analyses identified seven potentially...

10.1093/hmg/ddt532 article EN Human Molecular Genetics 2013-10-26

Objective To demonstrate pharmacokinetic equivalence of CT-P10 and innovator rituximab (RTX) in patients with rheumatoid arthritis (RA) inadequate responses or intolerances to antitumour necrosis factor agents. Methods In this randomised phase I trial, active RA were randomly assigned (2:1) receive 1000 mg RTX at weeks 0 2 (alongside continued methotrexate therapy). Primary endpoints area under the serum concentration–time curve from time zero last quantifiable concentration (AUC 0–last )...

10.1136/annrheumdis-2016-209540 article EN cc-by-nc Annals of the Rheumatic Diseases 2016-09-13

Objective. Evidence for the role of autophagy in regulation inflammation, especially IL-1β expression response to monosodium urate (MSU) crystals, is presented. This study investigated p62, a selective receptor autophagy, production MSU crystal-induced inflammation. Methods. IL-1β, TNF-α and IL-6 mRNA was measured by quantitative real-time PCR (qRT-PCR). Autophagy-related molecules such as Cullin-3, microtubule-associated protein 1 light-chain 3 (LC3) I/II, ubiquitin, caspase-1...

10.1093/rheumatology/ket474 article EN Lara D. Veeken 2014-02-28

Background and Objectives: Hematological indices have been known to be available markers used for evaluating disease activity in rheumatoid arthritis (RA). This study serves verify the association between four different hematological measures patients with RA. Materials Methods: The included 257 female RA 71 age-matched controls. Four indices, namely systemic immune-inflammation index (SII), neutrophil-to-hemoglobin lymphocyte (NHL) score, neutrophil-to-lymphocyte ratio (NLR),...

10.3390/medicina59010117 article EN cc-by Medicina 2023-01-06
Coming Soon ...